Issue 4/2019
Content (14 Articles)
Low-dose radiotherapy: Mayday, mayday. We’ve been hit!
Oliver J. Ott, Oliver Micke, Ralph Mücke, Marcus Niewald, Franz Rödel, Ulrich Schäfer, M. H. Seegenschmiedt, Meritxell Arenas, Benjamin Frey, Udo S. Gaipl
Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study
Paul Rogowski, Stephan Schönecker, Montserrat Pazos, Daniel Reitz, Michael Braun, Martin Pölcher, Claus Hanusch, Rachel Wuerstlein, Nadia Harbeck, Sven Mahner, Claus Belka, Stefanie Corradini
Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1–2 N1 disease
Omar Abdel-Rahman
Comment to Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease; an individual patient data analysis of three clinical trials
Christiane Matuschek, David Krug, Rainer J. Klement, René Baumann
A comparison of a brachytherapy and an external beam radiotherapy boost in breast-conserving therapy for breast cancer: local and any recurrences
Isabelle Kindts, Karolien Verhoeven, Annouschka Laenen, Melissa Christiaens, Hilde Janssen, Aline Van der Vorst, Erik Van Limbergen, Caroline Weltens
Hyperthermic chest wall re-irradiation in recurrent breast cancer: a prospective observational study
C. De-Colle, N. Weidner, V. Heinrich, S. Brucker, M. Hahn, K. MacMillan, U. Lamprecht, S. Gaupp, O. Voigt, D. Zips
Comparison of treatment plans for a high-field MRI-linac and a conventional linac for esophageal cancer
Marcel Nachbar, David Mönnich, Paul Kalwa, Daniel Zips, Daniela Thorwarth, Cihan Gani
Functional recovery after surgical stabilization and postoperative radiotherapy due to metastases of long bones
Irenäus A. Adamietz, Michal J. Wolanczyk
Radiotherapy of epicondylitis humeri
Matthias G. Hautmann, Lukas P. Beyer, Christoph Süß, Ulrich Neumaier, Felix Steger, Franz Josef Putz, Oliver Kölbl, Fabian Pohl
Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study
Konrad Kokowski, Stefan Stangl, Sophie Seier, Martin Hildebrandt, Peter Vaupel, Gabriele Multhoff
Lokale Radiotherapie für Patienten mit einem neu diagnostizierten, metastasierten Prostatakarzinom
Matthias Guckenberger
Management immunologischer Nebenwirkungen von Patienten, die mit Immun-Checkpoint-Inhibitoren behandelt werden: ASCO Clinical Practice Guideline Summary
Mechthild Krause
Patienten mit metastatischer Rückenmarkskompression profitieren von rascher multidisziplinärer Diagnostik und Behandlung
Carsten Nieder